INmune Bio, Inc.
(NASDAQ : INMB)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen, Inc. -2.78%240.831.3%$820.70m
MRNAModerna, Inc. -6.05%65.640.0%$717.07m
NVAXNovavax, Inc. -3.00%105.1196.5%$673.14m
IMMUImmunomedics, Inc. -0.19%85.3711.0%$599.85m
GILDGilead Sciences, Inc. -2.06%63.711.0%$586.80m
REGNRegeneron Pharmaceuticals, Inc. -1.22%548.472.7%$439.67m
BIIBBiogen, Inc. -2.56%267.461.6%$324.45m
VRTXVertex Pharmaceuticals, Inc. -2.02%260.041.9%$322.54m
ILMNIllumina, Inc. -8.28%271.023.5%$287.16m
SRNESorrento Therapeutics, Inc. -4.09%9.041.5%$263.45m
ALXNAlexion Pharmaceuticals, Inc. -2.88%110.452.0%$258.88m
MNTAMomenta Pharmaceuticals, Inc. 0.15%52.343.0%$237.70m
BMRNBioMarin Pharmaceutical, Inc. -2.56%77.354.3%$233.37m
VXRTVaxart, Inc. 3.95%8.550.0%$222.15m
SGENSeattle Genetics, Inc. -1.05%179.056.0%$192.12m

Company Profile

INmune Bio, Inc. focuses on controlling components of the immune system to activate an immune response against cancer and Alzheimer’s disease. Its product pipeline INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer, and LIVNATE. The company was founded by Mark Lowdell in September 2015 and is headquartered in La Jolla, CA.